Curran Terrie

Director at ARQT; President and Chief Executive at PHAT; Director at Myovant Sciences Ltd., and 1 more

Sold, on record
$5M
Dollars the filings state
Form 4 sales
14
Latest Aug 27, 2026
Form 144 notices
1
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale PHATPlan not stated
    Mar 1, 2023 2023

    Sold 1,436 shares at $8.54 ($12k)

    Curran Terrie, President and Chief Executive

    Sold 0.8% of holdings ($1.5M position)175,371 shares left0.2x usual sizeFiling

  2. 2 Form 4 sale PHATUnusual
    Mar 22, 2024 +387 days

    Sold 16,851 shares at $9.11 ($154k)

    Curran Terrie, President and Chief Executive

    No 10b5-1 planSold 3.9% of holdings ($3.9M position)410,784 shares left11x usual sizeFiling

  3. 3 Form 4 sale PHATUnusual
    Jul 15, 2024 +115 days

    Sold 33,848 shares at $11.72 ($397k)

    Curran Terrie, President and Chief Executive

    No 10b5-1 planSold 8.2% of holdings ($4.8M position)377,734 shares left9.2x usual sizeFiling

  4. 4 Form 144 notice ARQTNotice
    Nov 11, 2024 +119 days

    Filed to sell 8,687 shares ($94k)

    Curran Terrie, Director

    No 10b5-1 planFirst sale on recordFiling

  5. 5 Form 4 sale ARQTUnusual
    Nov 11, 2024 same day

    Sold 8,687 shares at $10.85 ($94k)

    Curran Terrie, Director

    No 10b5-1 planSold 46.1% of holdings ($204k position)10,139 shares leftFirst sale on recordFollows a Form 144Filing

  6. 6 Form 4 sale PHATNo plan
    Jan 21, 2025 +71 days

    Sold 19,109 shares at $6.59 ($126k)

    Curran Terrie, President and Chief Executive

    No 10b5-1 planSold 5% of holdings ($2.5M position)360,465 shares left1.1x usual sizeFiling

  7. 7 Form 4 sale ARQTNo plan
    Aug 20, 2026 +576 days

    Sold 1,072 shares at $26.04 ($28k)

    Curran Terrie, Director

    No 10b5-1 planSold 4.4% of holdings ($641k position)23,526 shares leftFiling

  8. 8 Form 4 sale ARQTUnusual
    Aug 27, 2026 +7 days

    Sold 38,200 shares at $25.03 ($956k)

    Curran Terrie, Director

    No 10b5-1 planSold 61.9% of holdings ($1.5M position)23,526 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Curran Terrie
Source
Aug 27, 2026Aug 28, 2026ARQTDirectorForm 4 sale38,200$956k61.9%UnusualSEC
Aug 20, 2026Aug 24, 2026ARQTDirectorForm 4 sale1,072$28k4.4%No planSEC
Jan 21, 2025Jan 23, 2025PHATPresident and Chief ExecutiveForm 4 sale19,109$126k5.0%No planSEC
Nov 11, 2024Nov 13, 2024ARQTDirectorForm 4 sale8,687$94k46.1%UnusualSEC
Nov 11, 2024Nov 12, 2024ARQTDirectorForm 144 notice8,687$94kNoticeSEC
Jul 15, 2024Jul 17, 2024PHATPresident and Chief ExecutiveForm 4 sale33,848$397k8.2%UnusualSEC
Mar 22, 2024Mar 26, 2024PHATPresident and Chief ExecutiveForm 4 sale16,851$154k3.9%UnusualSEC
Mar 1, 2023Mar 3, 2023PHATPresident and Chief ExecutiveForm 4 sale1,436$12k0.8%Plan not statedSEC
Jan 20, 2023Jan 20, 2023PHATPresident and Chief ExecutiveForm 4 sale5,821$48k3.2%Plan not statedSEC
Nov 21, 2022Nov 23, 2022PHATPresident and Chief ExecutiveForm 4 sale1,526$15k1.8%Plan not statedSEC
Sep 9, 2021Sep 13, 2021Myovant Sciences Ltd.DirectorForm 4 sale4,850$124k100.0%UnusualSEC
Sep 2, 2021Sep 3, 2021Myovant Sciences Ltd.DirectorForm 4 sale48,508$1.2M100.0%UnusualSEC
Mar 22, 2021Mar 23, 2021PHATPresident and Chief ExecutiveForm 4 sale11,513$499k100.0%UnusualSEC
Sep 18, 2019Sep 19, 2019CELGENE CORP /DE/OfficerForm 4 sale11,338$1.1M84.0%UnusualSEC
Sep 25, 2017Sep 26, 2017CELGENE CORP /DE/OfficerForm 4 sale1,727$248k30.6%UnusualSEC